GNRH1 and cancer: A study in cancer patients undergoing fertility preservation found that patients triggered with a GnRH agonist had increased number and percentage of oocytes in the Meiosis II phase, as well as increased fertilization rates and increased number of 2PN embryos compared to patients treated with hCG trigger (23).